WarrenChowMD

Oncology • Orange, CA

Melanoma, Sarcoma

Clinical Professor

Join to view full profile

Dr. Chow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Chow's full profile

Already have an account?

Office
101 The City Dr S
Orange, CA 92868
Phone+1 714-456-5153

Fax+1 714-456-5280

Education & Training

Cedars-Sinai Medical CenterResidency, Internal Medicine, 1986 - 1990
Cedars-Sinai Medical CenterInternship, Internal Medicine, 1986 - 1987
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1986

Certifications & Licensure

CA State Medical License 1987 - 2027
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2007-2013
Top Doctors:Southern California Castle Connolly, 2012
Join now to see all

Clinical Trials

Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma Start of enrollment: 2011 Apr 01
Completed
Phase 2
Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung Start of enrollment: 2013 Apr 01
Terminated
Phase 2
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes Start of enrollment: 2014 Jul 01
Completed
Phase 2
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Start of enrollment: 2015 Sep 14
Active, not recruiting
Phase 3
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study Start of enrollment: 2018 Apr 09
Recruiting
Phase 1
Study of SGN1 in Patients With Advanced Solid Tumor Start of enrollment: 2023 Jan 16
Recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

1 citations
A Pilot Study of Pembrolizumab Combined With Stereotactic Ablative Radiotherapy for Patients With Advanced or Metastatic Sarcoma.
Jeremy P Harris, Jino Park, Eric Ku, Steven Seyedin, Russell Stitzlein
Cancer Control. 2024-03-07
Phosphaturic mesenchymal tumor withliver metastases: a case report and literature review.
Sami Dwabe, Warren Chow
Therapeutic Advances in Medical Oncology. 2024-01-01
The Correlation Between Lymphocyte Nadir and Radiation Therapy for Soft Tissue Sarcoma: Defining Key Dosimetric Parameters and Outlining Clinical Significance.
Eric Ku, Garrett Harada, Elaine Chiao, Pranathi Rao, Sina Hosseinian
Advances in Radiation Oncology. 2024-01-01

Press Mentions

Extended Chemo Extends Life for Children with Rare CancerJune 3rd, 2018
Random Mutations May Be Leading Cause of OncogenesisApril 11th, 2017
Random Mutations May Be Leading Cause of OncogenesisApril 11th, 2017
Join now to see all